Home Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
 

Keywords :   


Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases

2014-01-13 12:01:01| Biotech - Topix.net

Genzyme, a Sanofi company , and Alnylam Pharmaceuticals, Inc. announced today that they have significantly expanded their strategic agreement to develop and commercialize treatments for rare genetic diseases.

Tags: expand rare collaboration diseases

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Farm Progress America, July 1, 2024
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
More »